Cardiovascular protection during cancer treatment is critical to help prevent complications such as heart failure. Patients should be educated on risk factors, symptom awareness, and heart-healthy behaviors. Oncologists should incorporate cardiovascular risk assessment and surveillance into treatment planning, while general cardiologists should understand the potential cardiotoxic effects of cancer therapies and partner closely with oncology teams to support long-term patient health.
In this interview, Dipti Itchhaporia MD, MACCand Ana Barac, MD, PhD, FACCdiscussUmbrella:CardioprotectionDuring Treatment.
Podden och tillhörande omslagsbild på den här sidan tillhör
American College of Cardiology. Innehållet i podden är skapat av American College of Cardiology och inte av,
eller tillsammans med, Poddtoppen.